Phase I/II trial of AMZ 0026 patients seropositive for HIV-1.
Not yet recruiting
Phase of Trial: Phase I/II
Latest Information Update: 20 Mar 2012
At a glance
- Drugs AMZ 0026 (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions; Therapeutic Use
- 20 Mar 2012 Planned number of patients changed to 32.
- 20 Mar 2012 New trial record